Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0901 USD | -10.79% | -4.25% | -31.74% |
May. 20 | Immunome Completes Purchase of Antibodies From Atreca | MT |
May. 20 | Immunome, Inc. completed the acquisition of Substantially all Assets of Atreca, Inc.. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.74% | 3.57M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.61% | 21.97B | |
-4.55% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- BCEL Stock
- News Atreca, Inc.
- Baird Adjusts Atreca's Price Target to $9 From $12, Keeps Outperform Rating